Thrilled to run our multidisciplinary thoracic oncology clinic in the new NCCS building! @dukenus @SingHealthSG
Latest posts 5
After five excellent webinars covering different aspects of RWE, please join us on 16 Dec Friday 8.15 am (GMT+8) to discuss the key highlights in our series and identify opportunities for drug development in Asia @herbloong @apoddc linkedin.com/posts/apoddc-p…
A negative trial that was designed after CM012 where there were 4/8 objective responses in EGFR M+. Underscores the limitation of subgroup analysis and importance of following up observations with validation trials! sciencedirect.com/science/articl… #lcsm @SingHealthSG @dukenus
Always important to additional metrics from RWE to predict for long term disease outcomes
RWE; patients progression free at 2y of IO have a mOS over 5y (rwOS 66.2m). Astonishing and great to see this formally measured. Helps counsel patients #ASCO22 #lcsmView quoted post on X
Thanks you Mariano Provencio @MARIANOPROVENCI for pioneering trials in this space and showing us how high we can fly! #icarus #NADIM @gecp_org @TheLancetOncol @stephanieplsaw
Thanks to Daniel Tan @danieltanmd and Stephanie Saw @stephanieplsaw for including SLCG @gecp_org trials #NADIM an #NATCH in this Updated review on neoadjuvant therapy in NSCLC in @TheLancetOncolView quoted post on X